Boston Partners’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
SI
BPCM
PGCM
GI
AA
Boston Partners's DBD Position: Q4 2022 in Review
Boston Partners sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 609,887 shares — an estimated $1.49M sold.
Boston Partners first reported a position in DBD in Q2 2020 and held it in 10 quarters. The position peaked at $3.32M in Q2 2021. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.
- Boston Partners reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
- Boston Partners sold 609,887 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $1.49M.
- Boston Partners first reported a position in Diebold Nixdorf Incorporated in Q2 2020 and held it in 10 quarters.
- Boston Partners's Diebold Nixdorf Incorporated position peaked at $3.32M in Q2 2021.
- 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.
Based on Boston Partners's 13F filing for Q4 2022, filed 8 Feb 2023.